| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS, Director | C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE | /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook | 18 Aug 2025 | 0001870913 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIP | Common Stock | Sale | $4,206,455 | -47,010 | -7.4% | $89.48 | 584,910 | 14 Aug 2025 | Held by Esjay LLC | F1, F2 |
| transaction | ANIP | Common Stock | Sale | $4,618,078 | -52,990 | -9.1% | $87.15 | 531,920 | 15 Aug 2025 | Held by Esjay LLC | F2, F3 |
| holding | ANIP | Common Stock | 92,588 | 14 Aug 2025 | Direct | ||||||
| holding | ANIP | Common Stock | 5,000 | 14 Aug 2025 | Held by SS Pharma LLC | F4 |
| Id | Content |
|---|---|
| F1 | The shares were sold in multiple trades at prices ranging from $88.20 to $90.11. The price reported above reflects the weighted average sales price. |
| F2 | The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| F3 | The shares were sold in multiple trades at prices ranging from $85.44 to $90.00. The price reported above reflects the weighted average sales price. |
| F4 | The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. |